Proteomic profiling of hyperplasia/atypia and adenoma-induced by NNK in mouse lung identified multiple proteins as potential biomarkers for early detection

Ferlay, 2008, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 (internet), Globocan, 2010, 12 Hecht, 2011, More than 500 trillion molecules of strong carcinogens per cigarette: use in product labelling?, Tob. Control, 20, 387, 10.1136/tc.2011.042853 Garcia, 2007, Global facts and figures 2007, Atlanta, GA: Am. Cancer Soc. Collins, 2007, Lung cancer: diagnosis and management, Am. Fam. Phys., 75, 56 Cancer facts and figures. American Cancer Society. 2014. Nikitin, 2004, Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium, Cancer Res., 64, 2307, 10.1158/0008-5472.CAN-03-3376 Bonner, 2004, Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas, Oncogene, 23, 1166, 10.1038/sj.onc.1207234 Malkinson, 1998, Molecular comparison of human and mouse pulmonary adenocarcinomas, Exp. Lung Res., 24, 541, 10.3109/01902149809087385 You, 1998, Preclinical and clinical models of lung cancer chemoprevention, Hematol. Oncol. Clin. North Am., 12, 1037, 10.1016/S0889-8588(05)70040-X Hecht, 1998, biology, and carcinogenicity of tobacco-specific N-nitrosamines, Chem. Res. Toxicol., 11, 559, 10.1021/tx980005y Hecht, 2009, Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers, Nat. Rev. Cancer, 9, 476, 10.1038/nrc2674 Wakamatsu, 2007, Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer, Toxicol Pathol., 35, 75, 10.1080/01926230601059993 Keith, 2013, Lung cancer chemoprevention: current status and future prospects, Nat. Rev. Clin. Oncol., 10, 334, 10.1038/nrclinonc.2013.64 Hecht, 2014, It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco, Cancer Prev. Res. (Phila.), 7, 639, 10.1158/1940-6207.CAPR-14-0095 IARC, 2007 Lu, 2006, Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine, Cancer Res., 66, 11494, 10.1158/0008-5472.CAN-06-1497 Yang, 1997, Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice, Cancer Res., 57, 1889 Wistuba, 2002, Smoking molecular damage in bronchial epithelium, Oncogene, 21, 7298, 10.1038/sj.onc.1205806 Bortner, 2009, Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis, J. Proteome Res., 8, 4050, 10.1021/pr900406g Wu, 2006, Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF, J Proteome Res., 5, 651, 10.1021/pr050405o Ross, 2004, Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents, Mol. Cell Proteomics, 3, 1154, 10.1074/mcp.M400129-MCP200 Bortner, 2011, Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking, J. Proteome Res., 10, 1151, 10.1021/pr100925p El-Bayoumy, 1992, Inhibition of 7,12-dimethylbenz(a) anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene) selenocyanate, Cancer Res., 52, 2402 Das, 2003, Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene) selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse, Nutr. Cancer, 46, 179, 10.1207/S15327914NC4602_11 El-Bayoumy, 1985, Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a) pyrene, Cancer Res., 45, 3631 Taylor, 2007, The minimum information about a proteomics experiment (MIAPE), Nat. Biotechnol., 25, 887, 10.1038/nbt1329 Shilov, 2007, The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra, Mol. Cell Proteomics, 6, 1638, 10.1074/mcp.T600050-MCP200 Tang, 2008, Nonlinear fitting method for determining local false discovery rates from decoy database searches, J Proteome Res., 7, 3661, 10.1021/pr070492f Kassie, 2008, Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice, Carcinogenesis, 29, 610 Ashburner, 2000, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat. Genet., 25, 25, 10.1038/75556 Hecht, 1989, Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet, Carcinogenesis, 10, 1901, 10.1093/carcin/10.10.1901 Richie, 2006, The organoselenium compound 1,4-phenylenebis(methylene) selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung, Chem. Biol. Interact., 161, 93, 10.1016/j.cbi.2006.03.005 Shearn, 2008, Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro, Chem. Res. Toxicol., 21, 1631, 10.1021/tx800162p Wang, 2005, Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance, Cancer Detect. Prev., 29, 544, 10.1016/j.cdp.2005.09.010 Forrest, 2000, Carbonyl reductase, Chem. Biol. Interact., 129, 21, 10.1016/S0009-2797(00)00196-4 Doorn, 2004, Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal, Biochemistry., 43, 13106, 10.1021/bi049136q Lin, 2001, Detection of differentially expressed genes in mouse lung adenocarcinomas, Exp. Lung Res., 27, 217, 10.1080/019021401300053966 Rutters, 2006, Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice, Proteomic., 6, 3127, 10.1002/pmic.200500188 Ismail, 2000, Carbonyl reductase: a novel metastasis-modulating function, Cancer Res., 60, 1173 Takenaka, 2005, Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer, Cancer Epidemiol. Biomarkers Prev., 14, 1972, 10.1158/1055-9965.EPI-05-0060 Biaoxue, 2012, Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients, J. Exp. Clin. Cancer Res., 31, 70, 10.1186/1756-9966-31-70 Yano, 1996, Expression and roles of heat shock proteins in human breast cancer, Jpn. J. Cancer Res., 87, 908, 10.1111/j.1349-7006.1996.tb02119.x Sreedhar, 2004, Hsp90 isoforms: functions, expression and clinical importance, FEBS Lett., 562, 11, 10.1016/S0014-5793(04)00229-7 Porat, 2000, A 56-kDa selenium-binding protein participates in intra-Golgi protein transport, J. Biol. Chem., 275, 14457, 10.1074/jbc.275.19.14457 Chen, 2004, Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas, J. Pathol., 202, 321, 10.1002/path.1524 Huang, 2012, Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness, Clin Cancer Res., 18, 3042, 10.1158/1078-0432.CCR-12-0183 Agresti, 2003, HMGB proteins and gene expression, Curr. Opin. Genet. Dev., 13, 170, 10.1016/S0959-437X(03)00023-6 Lotze, 2005, High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal, Nat. Rev. Immunol., 331, 10.1038/nri1594 Riuzzi, 2006, The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo, J. Biol. Chem., 281, 8242, 10.1074/jbc.M509436200 Taguchi, 2000, Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases, Nature, 405, 354, 10.1038/35012626 Shen, 2009, The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer, Oncol. Rep., 22, 535